Bausch & Lomb

There were unruly scenes in the House of Commons this week as UK prime minister Theresa May pleaded with boorish MPs to give her Brexit deal – painsta(...)

Contact lens manufacturer Bausch & Lomb has announced an expansion of its production facilities in Waterford in a move that is likely to lead to a(...)

Never has a toxin been so good for a town, a country or a company. In fact, Botox has been such a profit driver for Allergan, the multinational headq(...)

Contact lens giant Bausch & Lomb has opened an €85 million extension at its Waterford manufacturing base creating an extra 125 jobs. Three years (...)

Valeant Pharmaceuticals International will sell billions of dollars in assets to pay down debt and focus on businesses such as dermatology and Bausch (...)

As recently as last summer, J Michael Pearson styled himself as a brash and bold executive with a new way of thriving in pharmaceuticals: buying othe(...)

What is the right way to build up a drug company? Do you take the traditional route, investing in your own research and development and seeking to dis(...)

Valeant Pharmaceuticals, the Canadian drugmaker known for its serial acquisitions, reported first-quarter profit that topped analysts’ estimates and r(...)

Less than a year after it was on the verge of closing its Waterford manufacturing base and shedding 1,100 employees, contact lens giant Bausch & L(...)

Eye-care company Bausch & Lomb is to create 50 new jobs over the next 18 months as part of a €41 million investment at its Waterford facility.The (...)